Bringing the fundamentals into focus…
Back to Erasca, Inc.
How Erasca, Inc. stacks up
ERAS · against 230 other Healthcare companies of similar size
Overall
35/ 100
Near the bottom of its peers.
Ranked #199 of 231 · scores higher than 13% of peers
Bars: peers in each 10-point band of the overall score32 peers with an overall score of 30–39, including ERAS · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around ERAS| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 3 | 2.7B USD | 84 | 75 | 98 | 99 | 1 / 2 | |
| 4 | 18.3B DKK (≈$2.7B) | 81 | 86 | 74 | 86 | 0 / 2 | |
| 5 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 196 | 7.7B USD | 37 | 41 | 24 | 47 | 1 / 2 | |
| 198 | 7.7B USD | 36 | 8 | — | 9 | 0 / 2 | |
| 199 | 3.0B USD | 35 | 56 | 36 | 39 | 2 / 2 | |
| 199 | 3.4B USD | 35 | 8 | — | 12 | 0 / 2 | |
| 199 | 5.1B USD | 35 | 8 | — | 12 | 0 / 2 | |
| 202 | 2.8B USD | 33 | 57 | 28 | 30 | 2 / 2 | |
| 202 | 4.5B USD | 33 | 33 | — | 16 | 1 / 2 | |
| 202 | 9.0B USD | 33 | 8 | — | 23 | 1 / 2 | |
| 202 | 3.0B CHF (≈$3.5B) | 33 | 32 | 14 | 44 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score